As would be expected, high AHR expression and activity was usually, although not always [87], correlated with up-regulated CYP1A1 and/or CYP1B1 in cancers of the GI tract, bladder, head and neck, and breast [84,106,119,121,122,123]. This evidence concerns the gene CYP1A1 and cancer.